EUR 13.8
(-1.43%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 141.77 Million EUR | -3.75% |
2022 | 147.3 Million EUR | -5.37% |
2021 | 155.66 Million EUR | -0.57% |
2020 | 156.56 Million EUR | -6.86% |
2019 | 168.1 Million EUR | 61.32% |
2018 | 104.2 Million EUR | 3493.1% |
2017 | 2.9 Million EUR | 0.0% |
2016 | 2.9 Million EUR | -78.68% |
2015 | 13.6 Million EUR | -91.19% |
2014 | 154.3 Million EUR | -77.81% |
2013 | 695.4 Million EUR | -10.04% |
2012 | 773 Million EUR | 0.0% |
2011 | - EUR | 0.0% |
2010 | - EUR | 0.0% |
2009 | - EUR | -100.0% |
2008 | 729.39 Million EUR | 0.0% |
2007 | - EUR | 0.0% |
2006 | - EUR | 0.0% |
2005 | - EUR | 0.0% |
2004 | - EUR | -100.0% |
2003 | 179.76 Million EUR | -17.91% |
2002 | 218.98 Million EUR | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 141.8 Million EUR | 0.02% |
2024 Q2 | 141.82 Million EUR | 0.02% |
2023 Q4 | 141.77 Million EUR | 0.02% |
2023 Q3 | 141.75 Million EUR | 2574.55% |
2023 Q2 | 5.3 Million EUR | -96.26% |
2023 Q1 | 141.7 Million EUR | -3.8% |
2023 FY | 141.77 Million EUR | -3.75% |
2022 Q2 | 154.4 Million EUR | 3.91% |
2022 Q4 | 147.3 Million EUR | -0.9% |
2022 Q3 | 148.64 Million EUR | -3.73% |
2022 Q1 | 148.59 Million EUR | -4.54% |
2022 FY | 147.3 Million EUR | -5.37% |
2021 Q2 | 7.1 Million EUR | -95.22% |
2021 FY | 155.66 Million EUR | -0.57% |
2021 Q4 | 155.66 Million EUR | 4.8% |
2021 Q1 | 148.48 Million EUR | -5.16% |
2021 Q3 | 148.53 Million EUR | 1992.07% |
2020 Q2 | 8.9 Million EUR | -94.38% |
2020 Q1 | 158.34 Million EUR | -5.8% |
2020 Q3 | 8.4 Million EUR | -5.62% |
2020 Q4 | 156.56 Million EUR | 1763.81% |
2020 FY | 156.56 Million EUR | -6.86% |
2019 Q1 | 99.53 Million EUR | -4.47% |
2019 FY | 168.1 Million EUR | 61.32% |
2019 Q2 | 99.55 Million EUR | 0.01% |
2019 Q3 | 9.9 Million EUR | -90.06% |
2019 Q4 | 168.1 Million EUR | 1597.98% |
2018 Q3 | 2.8 Million EUR | -6.67% |
2018 Q4 | 104.2 Million EUR | 3621.43% |
2018 FY | 104.2 Million EUR | 3493.1% |
2018 Q1 | 2.7 Million EUR | -6.9% |
2018 Q2 | 3 Million EUR | 11.11% |
2017 Q4 | 2.9 Million EUR | -6.45% |
2017 FY | 2.9 Million EUR | 0.0% |
2017 Q1 | 2.7 Million EUR | -6.9% |
2017 Q3 | 3.1 Million EUR | 29.17% |
2017 Q2 | 2.4 Million EUR | -11.11% |
2016 FY | 2.9 Million EUR | -78.68% |
2016 Q1 | 10 Million EUR | -26.47% |
2016 Q4 | 2.9 Million EUR | -6.45% |
2016 Q2 | 10 Million EUR | 0.0% |
2016 Q3 | 3.1 Million EUR | -69.0% |
2015 FY | 13.6 Million EUR | -91.19% |
2015 Q4 | 13.6 Million EUR | 36.0% |
2015 Q3 | 10 Million EUR | 0.0% |
2015 Q2 | 10 Million EUR | 0.0% |
2015 Q1 | 10 Million EUR | -93.52% |
2014 Q2 | 161.75 Million EUR | -60.42% |
2014 Q3 | 152.82 Million EUR | -5.52% |
2014 Q1 | 408.65 Million EUR | -41.23% |
2014 Q4 | 154.3 Million EUR | 0.97% |
2014 FY | 154.3 Million EUR | -77.81% |
2013 Q2 | 752.64 Million EUR | 2.55% |
2013 FY | 695.4 Million EUR | -10.04% |
2013 Q1 | 733.96 Million EUR | -5.05% |
2013 Q4 | 695.4 Million EUR | -3.66% |
2013 Q3 | 721.8 Million EUR | -4.1% |
2012 Q2 | - EUR | 0.0% |
2012 Q3 | 724.83 Million EUR | 0.0% |
2012 Q4 | 773 Million EUR | 6.65% |
2012 FY | 773 Million EUR | 0.0% |
2012 Q1 | - EUR | -100.0% |
2011 Q3 | - EUR | 0.0% |
2011 Q4 | 971.6 Million EUR | 0.0% |
2011 FY | - EUR | 0.0% |
2011 Q1 | - EUR | 0.0% |
2011 Q2 | - EUR | 0.0% |
2010 Q4 | - EUR | 0.0% |
2010 FY | - EUR | 0.0% |
2010 Q1 | - EUR | 0.0% |
2010 Q3 | - EUR | 0.0% |
2010 Q2 | - EUR | 0.0% |
2009 Q4 | - EUR | 0.0% |
2009 FY | - EUR | -100.0% |
2008 FY | 729.39 Million EUR | 0.0% |
2007 FY | - EUR | 0.0% |
2006 FY | - EUR | 0.0% |
2005 FY | - EUR | 0.0% |
2004 FY | - EUR | -100.0% |
2003 FY | 179.76 Million EUR | -17.91% |
2002 FY | 218.98 Million EUR | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Fresenius Medical Care AG & Co. KGaA | 10.48 Billion EUR | 98.648% |
Fresenius SE & Co. KGaA | 13.24 Billion EUR | 98.93% |
LIMES Schlosskliniken AG | 10.09 Million EUR | -1305.108% |
M1 Kliniken AG | 1.87 Million EUR | -7461.387% |
Maternus-Kliniken Aktiengesellschaft | 53.96 Million EUR | -162.728% |
MEDICLIN Aktiengesellschaft | 66.41 Million EUR | -113.458% |
VITA 34 AG | 3.38 Million EUR | -4085.887% |